跳至主要内容
临床试验/NCT05272189
NCT05272189已完成不适用

Project 3 Example: Human-AI Collaboration Tester (HAICT) Exp. 7

Brigham and Women's Hospital2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Criterion

研究概览

简要总结

The study is one part of a "bundle" of experiments that constitute Project Three of a National Eye Institute grant. Project Three includes a series of experiments that investigate how changing the input from a simulated AI can affect the decisions made by human observers in a two-alternative forced choice task (like the decision to recall a woman for further examination in mammography). HAICT 7, the experiment described here, investigates how changing prevalence affects human performance when AI is used as a Second Reader.

详细描述

This text is the text of the pre-registration for the HAICT 7 experiment as described on the Open Science Framework. https://osf.io/hngu4/

NOTE: This study is representative of studies conducted in Project 3 of this grant. There are multiple experiments in the bundle of experiments represented by Project 3 but it is not possible to register a bundle of studies on CT.gov.

NOTE: Since the pronoun comment is advisory, we will leave it for now.

Human-AI Collaboration Tester (HAICT) Exp. 7 (lightly edited from OSF)

  1. Data collection. Have any data been collected for this study already? (Yes/No)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

盲法说明

Participants are naive to the purposes of the study but they are not blinded to the conditions.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - All welcome to enroll on line

排除标准

  • Must pass the Ishihara color vision screening test
  • 20/25 vision (with correction)

结局指标

主要结局

Criterion

时间窗: Up to one week

Criterion is the signal detection theory measure of the bias ("liberal" or "conservative") of observers' decisions

D'

时间窗: Up to one week

D' (d-prime) is the signal detection theory measure of the level of performance on a task.

次要结局

  • Reaction Time(Up to one week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeremy M Wolfe, PhD

Professor

Brigham and Women's Hospital

研究点 (2)

Loading locations...

相似试验

进行中(未招募)
不适用
A phase III trials program exploring the integration of Bevacizumab, Everolimus (RAD001), and Lapatinib into current neoadjuvant chemotherapy regimes for primary breast cancer - GeparQuinto
EUCTR2006-005834-19-DEGBG Forschungs GmbH2,727
已完成
不适用
Pilot Study of New Computer-based Neuropsychological Tool: Visual Tests, Touch ResponsesCerebral Neurological Illness
NCT03502603NYU Langone Health137
已完成
不适用
Multi-Component Breath Alcohol InterventionAlcohol UseAlcohol DrinkingDrinking Behavior
NCT06124898Northeastern University24
已完成
不适用
Effect of the Group-based Paro Intervention on Physiological and Psychological OutcomesDementia, MildDementia ModerateCognitive Impairment
NCT05102201National Tainan Junior College of Nursing118
进行中(未招募)
不适用
Estudio multicéntrico de fase III para investigar la eficacia y la seguridad del tratamiento abierto de 3 meses con PGL4001, seguido de un periodo aleatorizado, doble ciego y controlado con placebo de 10 días con progestina en pacientes con miomas y sangrado uterino abundante.A Phase III, multicentre, clinical study investigating the efficacy and safety of 3-months open-label treatment with PGL4001, followed by a randomised, double-blind placebo controlled period of 10 days treatment with progestin, in subjects with myomas and heavy uterine bleeding. - PEARL III: PGL4001 Efficacy Assessment in Reduction of symptoms due to uterine Leiomyomata
EUCTR2010-018999-25-ESPregLem S.A.200